$36.51 +0.31 (%) Myriad Genetics Inc - NASDAQ

Jan. 26, 2015 | 03:19 PM

Partner Headlines

  1. Big Short Interest On These 5 Biotech Stocks

    Benzinga | Jan. 12, 2015 | 15:36PM EST
  2. Barclays Initiates Coverage On Life Science Tools & Diagnostics, Names Thermo Fisher As 'Top Pick'

    Benzinga | Jan. 7, 2015 | 16:41PM EST
  3. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  4. AstraZeneca

    IBD | Dec. 19, 2014 | 18:25PM EST
  5. A Closer Look At 5 Heavily Shorted Stocks

    Benzinga | Dec. 12, 2014 | 11:02AM EST
  6. Study Shows Prolaris Could Save Healthcare System $6B Over 10 Yrs.

    Benzinga | Dec. 2, 2014 | 07:03AM EST
  7. Myriad Genetics' Crescendo Bioscience Offers New Clinical Data on Vectra(R) DA at ACR

    Benzinga | Nov. 19, 2014 | 07:07AM EST
  8. Top Performing Industries For November 12, 2014

    Benzinga | Nov. 12, 2014 | 10:59AM EST
  9. UPDATE: Morgan Stanley Initiates Coverage On Myriad Genetics As Survey Points To Greater Share Loss

    Benzinga | Nov. 10, 2014 | 09:15AM EST
  10. Benzinga's Top Initiations

    Benzinga | Nov. 10, 2014 | 09:04AM EST
  11. Crescendo Bioscience To Feature New Data On Vectra DA At 2014 ACR Meeting

    Benzinga | Nov. 10, 2014 | 07:43AM EST
  12. MYRIAD GENETICS

    IBD | Nov. 4, 2014 | 18:52PM EST
  13. Earnings Scheduled For November 4, 2014

    Benzinga | Nov. 4, 2014 | 05:31AM EST
  14. Gene tester obtains coverage

    IBD | Oct. 17, 2014 | 18:43PM EST
  15. Myriad Gets Reimbursement OK On Prostate Cancer Test

    IBD | Oct. 17, 2014 | 14:05PM EST
  16. Morning Market Losers

    Benzinga | Oct. 17, 2014 | 10:03AM EST
  17. Myriad Appoints R. Bryan Riggsbee As CFO

    Benzinga | Oct. 8, 2014 | 16:07PM EST
  18. Myriad Reports Tumor Bracanalysis CDX Has Identified 44% More Candidates for PARP Therapy

    Benzinga | Sep. 29, 2014 | 07:40AM EST
  19. Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed Treatment In 35 % Of Cases

    Benzinga | Sep. 9, 2014 | 07:08AM EST
  20. Myriad Publishes myRisk Hereditary Cancer Study In Cancer

    Benzinga | Sep. 3, 2014 | 16:06PM EST
  21. FuelCell Upgrade; Amazon Announces New Product

    Benzinga | Aug. 13, 2014 | 15:28PM EST
  22. SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

    Benzinga | Aug. 13, 2014 | 12:49PM EST
  23. Myriad Genetics Gets Mixed Analyst Reaction For Q2

    IBD | Aug. 13, 2014 | 12:13PM EST
  24. Markets Rise; Macy's Lowers Comparable Sales Outlook

    Benzinga | Aug. 13, 2014 | 10:59AM EST
  25. Morning Market Losers

    Benzinga | Aug. 13, 2014 | 09:51AM EST
  26. Myriad Genetics Guidance Disappoints, Q4 Edges Views

    IBD | Aug. 12, 2014 | 19:16PM EST
  27. Myriad issues weak guidance

    IBD | Aug. 12, 2014 | 18:51PM EST
  28. Earnings Scheduled For August 12, 2014

    Benzinga | Aug. 12, 2014 | 05:16AM EST
  29. Nasdaq Leads Up Session; Strong Earnings Lift Tata Motors

    IBD | Aug. 11, 2014 | 16:20PM EST
  30. Myriad Genetics' Earnings Face 'Angelina Jolie' Comps

    IBD | Aug. 11, 2014 | 12:43PM EST
  31. Top 4 Stocks In The Research Services Industry With The Highest Profit Margin

    Benzinga | Aug. 1, 2014 | 05:16AM EST
  32. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest EPS

    Benzinga | Jul. 18, 2014 | 04:36AM EST
  33. Some Stock Leaders Stay Firm Amid Pullback

    IBD | Jul. 10, 2014 | 18:43PM EST
  34. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD | Jul. 7, 2014 | 11:47AM EST
  35. Novo, Other Medicals Display Healthy Action

    IBD | Jun. 26, 2014 | 18:41PM EST
  36. A Few Medical Research Stocks Break Out, Others Basing

    IBD | Jun. 9, 2014 | 18:53PM EST
  37. MYRIAD GENETICS

    IBD | Jun. 9, 2014 | 18:39PM EST
  38. Quiet Session Intensifies As Stocks Hit Session Lows

    IBD | May. 6, 2014 | 15:01PM EST
  39. Stocks Extend Losses; AerCap Hits High On Earnings

    IBD | May. 6, 2014 | 11:56AM EST
  40. Myriad Genetics and UnitedHealthcare Sign 3 Yr Deal To Make Cancer Tests Available To United Members

    Benzinga | May. 6, 2014 | 07:16AM EST
  41. Earnings Scheduled For May 6, 2014

    Benzinga | May. 6, 2014 | 05:33AM EST
  42. Ubiquiti, Avis Budget Among 5 IBD 50 Stocks Reporting

    IBD | May. 3, 2014 | 08:02AM EST
  43. Why I Bought Myriad Genetics (MYGN)

    GuruFocus | Apr. 28, 2014 | 09:29AM EST
  44. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest Revenue

    Benzinga | Apr. 23, 2014 | 04:31AM EST
  45. Myriad Genetics Is Saving Lives With New Products

    IBD | Apr. 17, 2014 | 15:50PM EST
  46. Analyst Bullish On Medical Research, Equipment Stocks

    IBD | Apr. 8, 2014 | 13:33PM EST
  47. Myriad, Tata Motors Among RS Leaders In Correction

    IBD | Apr. 8, 2014 | 08:02AM EST
  48. UPDATE: Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)

    Benzinga | Apr. 7, 2014 | 16:31PM EST
  49. Avis Budget Leads 5 IBD 50 Stocks Holding Up Well

    IBD | Apr. 5, 2014 | 08:02AM EST
  50. Stocks Jump, Then Trim Gains; Anadarko, Align Rock Ahead

    IBD | Apr. 4, 2014 | 10:31AM EST
Trading Center